Ridley Corporation Limited · ASX:RIC
Ridley — Earnings Presentation (February 2005)
8 slides from Ridley's earnings presentation, Feb 14, 2005
Slide 1: Supplementary slides
UPPLEM
Slide 2: Sweetlix products, plants, brands and licenses
Products: 105,000 tons of Presset & Chemical (poured) blocks, and Loose mineral supplements: Plants: Alabama, Texas & Indiana Brands: “Sweetlix”,“VMS”, & “Futurity” we Licenses: New Animal Drug Applications (NADA the production of medicated blocks RBO customer: Major customer of RBO, distributin 470
Slide 3: Strategic fit: product offering, market position, marketing, geography
Product Offering: Ability to ly a greater range of supplement products to the combined: Market Position: Consolidates Ridley a “free choice supplements’ provider in North Marketing: Sweetlix will benefit from RBO marketing focus on the ‘value-add’ of chemical b where appropriate Geography: Provides
Slide 4: Sweetlix Facilities
lix Facilities te Fort Worth Siracuse®
Slide 5: Combined Sweetlix and RBO Facilities
ive Sweetlix Facilities 2s RBO Facilities
Slide 6: Acquisition terms and current year projection
¢ Acquired: assets of Sweetlix L 30% July 2004. * Price: US$16.7 m | ctrrentYear | projection _ Current Year Projection Tons (000) 103,706 115,040 Sales US $m 34.0 40.0 Gross Margin US $m 10.3 12.2 EBIT US $m 2.2 3.2 - multiple 7.7 5.3 EBITDA US $m 3.0 4.3 - multiple 5.6 3.9 * Annualised forecast
Slide 7: Business Integration: progressing to plan
Business Integration: progressing to plan Cost savings: up to US$1.Omillion of a savings to be achieved: > SLC Office closure > Staff Consolidation > Raw materials Hurricanes: Impacted production & logistics Forecast: EBITDA FY 2005 US$3.0 million
Slide 8: Sales Growth: drive to utilise broader product range
Sales Growth: Drive to utilise the benefits of a broader product range with greater market reac New Products: Planning to add innovative pe offerings to Sweetlix® existing product lines customer base. Cost management: Ensure that all cost synergies achieved Projection: EBITDA > US$4.0million